Article
Orlando, FL-The use of radiopharmaceutical carbon-11 acetate in positron emission tomography (PET) appears to be more sensitive in picking up recurrent prostate cancer than standard imaging techniques, according to preliminary imaging studies presented at the AUA annual meeting.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.